Mphasis Surges on Deal Wins; Analyst Maintains BUY

BROKERAGE-REPORTS
Whalesbook Logo
AuthorKavya Nair|Published at:
Mphasis Surges on Deal Wins; Analyst Maintains BUY
Overview

Mphasis reported Q3 revenue growth exceeding expectations, driven by a robust deal pipeline and platform strategy. Despite margin pressures from strategic investments and exceptional charges, analyst Prabhudas Lilladher maintains a BUY recommendation, setting a Rs 3,480 price target based on a 26x FY28E EPS multiple. The company's TCV pipeline shows significant year-over-year growth.

The Seamless Link

This performance underscores a strategic shift at Mphasis, where enhanced platform capabilities and a human-agent model are translating into deeper client engagement. The company's ability to convert its growing deal pipeline into tangible revenue, even amidst sector-wide headwinds and strategic investments, positions it for sustained growth in the evolving IT services landscape.

Deal Pipeline Fuels Growth Momentum

Mphasis's recent quarterly performance saw revenue growth of 1.5% quarter-on-quarter in constant currency, surpassing analyst expectations of 0.5%. This uplift was primarily attributed to steady revenue conversion and the successful ramp-up of significant new deals. The crucial Banking, Financial Services, and Insurance (BFSI) sector demonstrated resilience, posting a healthy 3.7% sequential increase [cite: Original text]. Performance outside BFSI faced some seasonal weakness, particularly in Technology, Media, and Telecommunications (TMT), while the Logistics division stabilized at a muted pace. Excluding logistics and transportation, Mphasis achieved approximately 16% year-on-year growth in the first nine months of fiscal year 2026 [cite: Original text]. The company's strategic focus on platforms and service delivery, integrated with a human-agent model, is evidently driving incremental engagement in large transformation deals, which increased to 14 in the first nine months of FY26 from 11 in the prior year [cite: Original text]. This surge in client confidence is reflected in the new deal Total Contract Value (TCV) of USD 428 million, a 22% year-on-year increase, contributing to a substantial 95% year-on-year jump in 9MFY26 deal TCV to USD 1.7 billion [cite: Original text, 10]. The broader Indian IT sector is also showing signs of recovery, with Q3 FY26 results indicating a potential end to the prolonged slowdown, driven by a growing focus on AI capabilities. While major peers like TCS and Infosys reported mixed results, with constant currency revenue growth ranging from -2.6% to 1.7% in Q3 FY26, Mphasis's performance in securing substantial contracts aligns with this cautiously optimistic sector outlook.

Margin Resilience Amidst Strategic Investment

Despite fluctuations in effort utilization, particularly a drop in the third quarter, Mphasis has managed to maintain its operating margins within a narrow band [cite: Original text]. The company's EBIT margin was reported at 15.2% for Q3 FY26, down 10 basis points quarter-on-quarter, partly due to a one-time exceptional charge of ₹35.5 crore related to India's new labour code. Several major Indian IT firms, including TCS, Infosys, and HCLTech, also reported significant one-time costs associated with these new labour regulations, totaling approximately ₹5,400 crore across the top six players. Mphasis intends to continue investing in proprietary platforms and intellectual property development, which is expected to keep margins within its guided band of 14.75%-15.75% [cite: Original text]. This strategic reinvestment, while potentially exerting near-term pressure, is aimed at enhancing future service offerings and driving long-term profitability, a sentiment echoed across the IT sector as companies pivot towards AI-centric engagements.

Analyst's Confident Outlook

Prabhudas Lilladher has reiterated its 'BUY' recommendation for Mphasis, projecting a revenue growth of 7.0% for FY26E, followed by 9.2% for FY27E and 10.7% for FY28E, all in constant currency. The brokerage firm anticipates EBIT margins to be around 15.3% in FY26E, climbing to 15.7% in FY27E and 16.0% in FY28E [cite: Original text]. This outlook supports their valuation approach, assigning a multiple of 26 times the fiscal year 2028 estimated earnings per share, which translates to a price target of Rs 3,480 [cite: Original text]. Mphasis currently trades with a P/E ratio in the range of 29.5x to 29.9x, which, while higher than some larger peers like TCS (23.55x) and Infosys (21.1x), is justified by its focused growth strategy and strong deal pipeline, according to the brokerage.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.